Skip to content

HCV viraemia means poorer immune response to HAART

Can corticosteroids delay the initiation of HAART?

Once-daily Kaletra approved for treatment-naive patients in USA (corrected)

Underestimating necessity for HAART, and concerns about side-effects, leads to low uptake and poor adherence

BHIVA issues draft 2005 treatment guidelines, calls for comments by May 3rd

European activists claim Pfizer's CCR5 antagonist trial unnecessarily putting most vulnerable at risk; US activists disagree

Spontaneous sustained undetectable viral load 'not rare' in newly infected

Mild neuropsychiatric disorders can persist for two years after starting efavirenz

HIV diagnosed later in Africans in south London